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Abstract: This study aims to investigate the action of rosemary oil on the immortalized keratinocyte cell line. Samples of Rosmarinus
officinalis that were growing uncultivated in central Turkey were harvested during flowering in May 2016. The rosemary oil was obtained
by the hydrodistillation of the dried ground material in a Clevenger-like apparatus. Human cells from the immortalized nontumorigenic
keratinocyte cell line were seeded at a concentration of 5000 cells/well on 96 well plates. Cell viability was measured at the 24, 48, and
72 h. Five different doses of 1.25% to 20% Rosmarinus officinalis oil, 20% DMSO (for toxic examination), and 1 negative control were
prepared. Highly significant differences were found between the doses (P < 0.01) as well as at different time points (P < 0.01).That is to
say that at 72 h, the results for mean ± SD cell vitalities for doses of 1.25, 2.5, 5, 10, 20, DMSO 20%, and the control were 0.099 ± 0.018,
0.077 ± 0.008, 0.038 ± 0.011, 0.022 ± 0.005, 0.011 ± 0.000, 0.009 ± 0.000, and 0.174 ± 0.011, respectively. There was a significant decrease
in the mean vitality from baseline (3.4%) to 48 h (2.0%) followed by a substantial increase at 72 h (6.1%) (P < 0.01). This study shows
that rosemary oil used in cell culture inhibits cell proliferation, which might be via the apoptotic pathway. We concluded that rosemary
oil at a concentration of 1.25% may help the organism to inhibit excessive cell proliferation in tissues covered with keratinocytes, which
may contribute to a healthy digestive system by stopping excessive cell proliferation and may be utilized in both animal feed and human
nutrition, via the apoptotic pathway.
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1. Introduction
More recently, rosemary is examined using modern
scientific methodology, and as a result of these
investigations, a lot of useful information about the plant
and its derivatives has been accumulated [1,2,3].
Rosemary (Rosmarinus officinalis, L.) is one of the
significant medicinal plants belonging to the Lamiaceae
family and has been widely used for different purposes
traditionally, including treatment and nutrition.
It was claimed that rosemary extract exhibits a variety
of pharmacological activities via its main chemical
compound, which includes carnosol, carnosic acid [4,5],
ursolic acid, rosmarinic acid [6], and caffeic acid [7,8].
Most of the recent studies aimed at finding a possible
mechanism of rosemary oil concerning its effects on tumor
cells. That is because the potential molecular mechanism
of its antiproliferative effect and the pharmacological
interactions among rosemary components are still
unknown [9,10,11]. Therefore, we hypothesized that
rosemary oil can induce apoptosis in cells by slowing
down or stopping cell division, leading to cell death.
Keratinocytes constitute 90% of the outermost layer of
the skin. These cells have a high capacity for proliferation,

which is tightly controlled under physiological conditions
[12].
Although the findings on the antiproliferative effect of
rosemary are well appreciated, the mechanisms of action
are not fully resolved. For example, in the in vitro study
on colon cancer cells, Pérez-Sánchez et al. commented
that the treatment with rosemary would lead to a heavy
increase of intracellular reactive oxygen species (ROS) and
high-level ROS could result in necrosis and cell death [10].
On the other hand, cytotoxic effects of rosemary will block
nuclear factor erythroid 2-related factor 2 (Nrf2) gene
expression. Thus, a sequence of events will be detected in
cell survival [9].
This study aims to investigate the antiproliferative
action of rosemary oil on the immortal keratinocyte
cell line and contribute to a better understanding of the
possible mechanism of this action.
2. Materials and methods
2.1. Plant material
Samples of rosemary spontaneously growing in Erzurum
(39.9055° N, 41.2658° E, at an altitude of 1800 m above
the mean sea level) were harvested during flowering in
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May 2016. The samples were identified by the Department
of Aromatic and Medicinal Plants Research, National
Institute of Agricultural and Food Technology (INIA),
Erzurum, Turkey. A voucher specimen was deposited for
internal control at the INIA.
Samples were dried and were kept in an oven at 35 °C
for 30 h. They were kept away from light and moisture
until the analysis.
2.2. Extraction process
The rosemary oil was obtained by hydrodistillation of the
dried ground material in a Clevenger-like apparatus for 2
h at atmospheric pressure of about 100 g of the sample.
The time taken was marked from the falling of the first
drop of the distillation. During the process, 2 replications
were performed. The rosemary oil yield was evaluated
gravimetrically. Based on the dry weight, the ratio was
1.7%
2.3. Cell culture
The immortalized nontumorigenic keratinocyte cell line of
human (HaCaT) was obtained from the Cell Culture and
Biological Resources Unit at Yeditepe University, Turkey.
These cells were seeded at a concentration of 5000 cells/
well on 96 well plates (BIOFIL, TPC, Switzerland) and
maintained in RPMI-1640 (Sigma Chemical Co., St. Louis,
MO), containing HEPES (Sigma) buffer supplemented
with 10% heat-inactivated Fetal Calf Serum (FCS) (Hyclone
Lab., Logan, UT), 100 U/ml penicillin (Sigma), and 100
μg/mL streptomycin (Sigma), in plastic disposable tissue
culture flasks at 37 °C in a 5% CO2 / 95% air incubator.
2.4. Cell viability
The cell viability was measured at 24, 48, and 72 h
using the 3-(4,5-dimethyl-thiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-phenyl)-2H
tetrazolium
measurement methods of cell proliferation (MTS) assay
(CellTiter96 Aqueous One Solution, Promega, UK).
Five different concentrations of 1.25%, 2.5%, 5%, 10%,
and 20% Rosmarinus officinalis oil, 20% dimethyl sulfoxide
(DMSO) as a toxic control, together with a nothingadded negative control were prepared in Dulbecco’s
Modified Eagle Medium (DMEM) including 10% Fetal
bovine serum (FBS) and 1% penicillin-streptomycinamphotericin (PSA).
On the evaluation day, the MTS solution was prepared
according to the manufacturer’s instructions, and cells
were treated with this solution. The plates were incubated
for 2 h in the dark at 37 °C. Cell viability depending on the
toxicity of Rosmarinus officinalis oil was measured by an
ELISA plate reader (Biotek, USA) at 490 nm absorbance.
2.5. Statistical analysis
Each experiment was carried out in triplicate. The results
were presented as mean ± standard deviation (SD) values
of at least 3 measurements. A 2-factor (Dose and Hours)

full chance trial plan was applied for both groups, and
the one-way analysis of variance (ANOVA) was used to
determine whether there are any statistically significant
differences between doses and hours. Differences among
the means were determined by the Duncan multiple
comparison test. A linear correlation analysis was used
to explore the relationships among the study. Correlation
coefficients (R) and P values were evaluated to judge the fit
of the correlation. Two-sided P < 0.05 and P < 0.01 values
of relationships were considered significant and highly
significant, respectively. All analyses were conducted using
the statistical package SPSS version 22.0 for Windows
(SPSS Inc., Chicago, IL, USA).
3. Results
According to the results of the variance analysis (Table
1), highly significant differences were found among the
doses at 24 h for rosemary oil (P < 0.01), and there was
no difference between 20% and 20% of DMSO (positive
control). Additionally, there was still no significant
difference between 2.5% and 5%, but the negative control,
1.25%, and 10% groups were significantly different (P <
0.01) from one another.
The values at 48 h showed significant differences among
the doses (P < 0.01). There was no difference between
20% and DMSO 20% (positive control), or between 5%
and 10%. However, the negative control, 1.25% and 2.5%
groups were significantly different (P < 0.01) from one
another (Table 1).
When the 72-h-data for rosemary oil were examined,
significant differences were found again among the doses
(P < 0.01). There was no difference between 20%, DMSO
20% (positive control), and 10%. However, 1.5%, 2.5%, 5%,
and the negative control group were significantly different
(P < 0.01), as shown in Table 1.
Also, there were significant differences between the
mean cell vitality measured at different time points. There
was a considerable decrease in the vitality at 48 h, followed
by a substantial increase at 72 h (Table 2).
4. Discussion
We have already studied the antioxidant effects of
rosemary in the previous section [13]. In this study, we
want to move the first topic a step further and examine
whether or not rosemary oil has antiproliferative effects
on the immortalized human keratinocyte nontumorigenic
cell line (HaCaT).
Although rosemary was investigated before, this study
contributes to the contemporary investigations in some
aspects. First, the effectiveness of rosemary was tested in
normal cells, not in pathological cells. Instead of plant
components, rosemary oil was used in the experiment
directly. Additionally, rosemary’s antiproliferative effect
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Table 1. Distributions of mean cell vitality between the different experimental groups.
Dose

24 h

Toxic control DMSO 20%

48 h

72 h

0.011 ± 0.001

a

0.008 ± 0.000

0.009 ± 0.000a

Negative control

0.073 ± 0.108e

0.047 ± 0.160d

0.174 ± 0.011e

1.25%

0.054 ± 0.008d

0.029 ± 0.005c

0.099 ± 0.018d

2.5%

0.035 ± 0.005

0.020 ± 0.001

0.077 ± 0.008c

5%

0.030 ± 0.002c

0.014 ± 0.004ab

0.038 ± 0.011b

10%

0.022 ± 0.003

0.014 ± 0.008

0.022 ± 0.005a

20%

0.013 ± 0.001a

0.009 ± 0.000a

0.011 ± 0.000a

P

<0.01

<0.01

<0.01

a

c

b

b

ab

Similar subscript letters designate the absence of significance. DMSO: Dimethyl sulfoxide.

Table 2. Inter-hour variance analysis.
Hour

X
_ ± SS

24

0.034 ± 0.001b

48

0.020 ± 0.001a

72

0.061 ± 0.001c

P

<0.01

was evaluated in an immortalized human keratinocyte
nontumorigenic cell line (HaCaT) in vitro. On the other
hand, the lack of generalizability in human subjects can be
mentioned as a limitation of this study.
Due to their high proliferative abilities, epithelial
cells are capable of regenerating themselves continuously
at almost every stage of postnatal life, just like in the
development process. The best example of this type of
cell is the epithelial cell, which covers the inner surface of
the digestive system from mouth to the anus. In addition,
regardless of whether they originate initially from the
ectoderm, mesoderm, or endoderm, or differentiate into
which epithelial tissue, despite the fact that the self-renewal
features are automatically revealed, it shows that they never
lose their multipotent stem or unipotent progenitor stem
cell potentials [12]. Of course, the activities of epithelial
cells are carried out by several mediators and signal
pathways, including mediators. There is an important fact
known of epithelial cells: these structures, regardless of
the embryological eugenics they originated from or the
type of epithelial tissue from which they differ, carry out
their normal functions and use the same type of signaling
pathways jointly [14,15,16,17]. One of the underlying
causes of many epithelial disorders characterized by
abnormal or uncontrolled proliferation, including cancers,
is perhaps the deregulation of the factors controlling their
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growth. Although the possible causes and mechanisms
leading to the deregulation are not yet fully elucidated,
they make the subject much more interesting [18,19]. A
number of questions can be asked in this context. How
can cells deviate from this pathway into the excessive
proliferation of cancer while following the periods of
proliferation, maturation, differentiation, and elimination
in the normal physiological state? Is it necessary to address
overgrowth and cancer events as a sequence of events or as
a result of different mechanisms? Regardless of the actual
triggering and/or dissociating mechanisms, is not there a
major intersection where these 2 realities intersect with
each other during their respective processes? If so, can
it be argued that this point of intersection is a matter of
oxidative stress?
If we start with the last question, oxidative stress in
itself is neither good nor bad; it is a normal phenomenon
in the body. In other words, under normal conditions,
many agents that we know causing oxidative stress (such as
superoxide radicals, hydrogen peroxide, hydroxyl radicals,
and singlet oxygen) are generated as metabolic redox
homeostasis and in vivo redox homeostasis [20,21].
If there is a problem, the source is not the formation
or existence of free radicals that arise from exogenous
origins (e.g., ultraviolet rays) or endogenous origins (at
the cellular level, at which mitochondria are involved) but
in an imbalance between free radicals and antioxidants in
the body. If this imbalance passes to the second stage, i.e.
oxidative stress due to excessive proliferation of cells in any
tissue or organ, the capacity of the oxidation-reduction
system of the body is exceeded. Thus, it would be almost
impossible not to face abnormalities such as direct gene
mutations or indirect carcinogenesis [22–24].
To ensure that the metabolism does not reach this
stage, measures such as slowing or stopping cell division
are activated. However, this applies only to certain healthy

ERHAN / Turk J Vet Anim Sci
cells. The answer produced against this process which
intersects the hypoxia junction at the end, is the opposite in
stem cells or cancer cells exhibiting stem-cell behavior, in a
sense. These cell populations maintain cell proliferation in
the face of hypoxia [25]. For most cell types, hypoxia induces
increased cell proliferation since an increased number
of cells, with a consequent increase in oxygen demand,
would only exacerbate hypoxic stress. Healthy cells behave
in this way but in cancer cells, certain cell populations
maintain cell proliferation in the face of hypoxia. This is
a common pathological hallmark of cancers, but it can
also serve the physiological function of maintenance
of stem cell populations that reside in a hypoxic niche
[25,26]. If we continue with the example of abnormal cell
proliferation, it is necessary to determine the relationship
between oxidative stress and abnormal cell proliferation.
The second thing to be done should be the evaluation of
other factors involved in the initiation, promotion, and
maintenance of this proliferative response. The third
point, the most difficult one, is to try to prevent situations
that cause abnormal proliferation, for example, oxidative
stress, to protect the body from the consequences that will
arise after the event, and, if it is possible, to cure this type
of disease, for example, tumor-like masses or proliferative
lesions by breaking the dilemma, which is known to have
a causal relationship between abnormal proliferation and
oxidative stress at that point. Research that will be done
without consideration of specific features of epithelial cells
and what can be the possible specific effects of rosemary
on such tissues will not be entirely consistent with the
facts. The explanation that overgrowth leads to oxidative
stress and that imbalance due to increased oxidative stress
that stops cell proliferation, seems to be the expected result
of a rational logic but will not be of any scientific value.
In this context, our surprising findings have once again
proved that the subject deserves attention. In this in vitro
study, we applied 5 different doses of rosemary oil to the
HaCaT and observed cell viability at 24, 48, and 72 h to
contribute to the understanding of epithelial cell biology,
which is known to be capable of exhibiting stem cell
behavior. These findings might contribute to the prevention
and/or treatment of certain diseases of epithelial origin that
are characterized by excessive division (such as psoriasis,
eczema, and ichthyosis of ectodermal origin) or of benign
and malignant epithelial pathologies of exothermal origin
that are very common in the gastrointestinal tract.
Our findings demonstrate that rosemary has
antiproliferative effects in keratinocytes regardless of the
dose and that the effect increases with the amount given.
However, not only the dose but also time indicates that
our results cannot be interpreted immediately and/or
easily without considering some complex mechanisms.
Further research is also needed to interpret the increase of

mean cell vitality at 74 h, after an initial decrease at 48 h.
Additionally, we observed that the variance of cell vitality
is decreasing with increasing doses of the rosemary oil
extract, which resembles the effects of DMSO 20%. Thus, it
can be considered that increasing dosage becomes similar
to the toxic control.
Although the antiproliferative effect of Rosmarinus
officinalis or its compounds has been successfully
demonstrated in many studies, there is minimal
information on the mechanism through which the plant
exerts this effect, and only a few investigations mention the
apoptosis pathway [27–29].
In 2016, carnosic acid, which is the most crucial bioactive
component in Rosmarinus officinalis, was shown to have
an apoptotic effect in CAKI cells through mitochondriadependent caspase activation and to interfere with the
signal transducer and activator of transcription (STAT3)
signaling pathway via the generation of ROS [28].
It is known that apoptosis, which is the choice of a
healthy metabolism to stop physiologically excessive cell
proliferation that occurs for any reason, is the second
method if necrosis fails. When each group of cells is exposed
to excessive proliferation due to pathological reasons such
as gene mutations, this time, if the immune and immuneendocrine system of the organism maintains its integrity,
it will force these cells to undergo the apoptosis pathway. If
this cannot be achieved, the option will be either necrosis
or carcinogenesis.
As a result of the direct contact of the metabolism
with both internal and external factors, epithelial cells,
which are at a high risk of mutation, have to be renewed
continuously due to hemostasis. This process, in one
aspect (continuous regeneration), provides an advantage
to the organism, while on the other hand, it carries the risk
of being exposed to mutation for any reason. It is precisely
this point where a dilemma arises. Given the functions
mentioned above regarding the gastrointestinal tract, one
would not exaggerate to assume a higher risk than other
epithelial tissues. Moreover, in any possible defects of this
system, the cells begin to regenerate abnormally, which in
turn adversely affect digestion, and in later stages, lead to
the collapse of the whole organism.
This study suggests that rosemary oil used in the
cell culture inhibited excessive cell proliferation by the
apoptotic pathway. We conclude that rosemary oil may
help living organisms to have a healthy digestive system
by stopping excessive cell proliferation via the apoptotic
pathway in the gastrointestinal system, and thus may be
used in both animal feed and human nutrition.
Furthermore, rosemary may contribute to the treatment
of a number of diseases in the oral mucosa called “tumorlike masses,” “proliferative lesions” or “benign soft tissue
lesions,” which may lead to nutritional disorders.
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